'European panel on low density lipoprotein (LDL) subclasses': a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary

Autor:	Mikhailidis, D P, Elisaf, M, Rizzo, M, Berneis, K, Griffin, B, Zambon, A, Athyros, V, de Graaf, J, März, W, Parhofer, K G, Rini, G B, Spinas, G A, Tomkin, G H, Tselepis, A D, Wierzbicki, A S, Winkler, K, Florentin, M, Liberopoulos, E
Přispěvatelé:	Mikhailidis, DP, Elisaf, M, Rizzo, M, Berneis, K, Griffin, B, Zambon, A, Athyros, V, de Graaf, J, März, W, Parhofer, KG, Rini, GB, Spinas, GA, Tomkin, GH, Tselepis, AD, Wierzbicki, AS, Winkler, K, Florentin, M, Liberopoulos, E, University of Zurich
Rok vydání:	2011
Předmět:	Electrophoresis Health aging / healthy living [IGMD 5] Magnetic Resonance Spectroscopy LDL subclasses atherosclerosis cardiovascular risk 10265 Clinic for Endocrinology and Diabetology 610 Medicine & health Atherosclerosis 2705 Cardiology and Cardiovascular Medicine Lipoproteins LDL 3004 Pharmacology Animals Humans Clinical Medicine Life Style Ultracentrifugation Monitoring Physiologic
Zdroj:	Current Vascular Pharmacology, 9, 531-2 Current Vascular Pharmacology, 9, 5, pp. 531-2
ISSN:	1570-1611
Popis:	Item does not contain fulltext
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b2135be93846844340739c863f37cc63 http://hdl.handle.net/2066/96555 Zobrazit plný text záznamu